Curious Case of Sglt2 Inhibitor: From the Apple Tree to Shifting Paradigm - European Medical Journal

Curious Case of Sglt2 Inhibitor: From the Apple Tree to Shifting Paradigm

Diabetes

Watch this webinar for:

  • An overview of the evolution of SGLT2is
  • How SGLT2is have shaped diabetes management
  • The use of SGTL2is in organ protection for both patients with and without diabetes

About the speaker:

James Kim is a general practitioner with a special interest in chronic diseases, especially diabetes and chronic migraine. He is a clinical assistant professor in the Department of Family Medicine, University of Calgary, Canada. After graduating in South Africa, he completed a post-graduate diploma in Diabetes in 2012 and is peer reviewer and editorial board member for numerous medical journals. Kim has given presentations on diabetes, chronic migraine, binge eating disorder and ADHD. Within Diabetes Canada, his roles include committee member for the Clinical Practice Guideline, co-chair of Primary Care Special Interest Group, and has been a scientific planning committee member for the Annual Diabetes Canada Conference.

Join our mailing list

To receive the EMJ updates straight to your inbox free of charge, please click the button below.
Join Now